Taurine for the Treatment of Canine Dilated Cardiomyopathy
Download in electronic PDF format for $75
Abstract: In dogs, dilated cardiomyopathy is a common cardiac disease that is associated with treatment failure, a progressively compromised quality of life, and eventual death from heart failure. Cardiomyopathy in companion animals is treated with a variety of drugs manufactured for the management of cardiac dysfunction in humans, but often those agents do not produce a significantly beneficial response in veterinary patients. In this article, Laura Ivan, DVM, presents her personal experience with the use of a compounded form of the amino acid taurine in the treatment of her Doberman pinscher, whose dilated cardiomyopathy was characteristically sudden in onset. Robert Borger, RPh, a specialist in veterinary compounding, comments on the preparation of taurine for use in dogs with dilated cardiomyopathy.
Related Keywords:
Jane Vail, dogs, dilated cardiomyopathy, heart disorders, cardiac disorders, congestive heart failure, taurine, amino acids, veterinary
Related Categories:
NUTRITION AND NUTRICEUTICALS, VETERINARY, CARDIOLOGY, DOSAGE FORMS/DRUG CARRIERS
Printer-Friendly Version
| Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Taurine for the Treatment of Canine Dilated Cardiomyopathy
Vail Jane
|
Nov/Dec 2006
Pg. 421-424
|
Veterinary Transdermal Medications: A to Z
Davidson Gigi S
|
Mar/Apr 2003
Pg. 106-113
|
Treating Canine Hepatic Disease
Davidson Gigi S
|
May/Jun 2003
Pg. 188-191
|
The Treatment of Canine Atopic Disease
Davidson Gigi S
|
May/Jun 2002
Pg. 210-215
|
Congestive Heart Failure and Other Medical Facts About Ferrets; Scout's Story: A Case Report on Treating Congestive Heart Failure in a Ferret
Williams LaVonn A, Riley Kari
|
Sep/Oct 2009
Pg. 367-371
|
Sensitization Therapy for Warts
Kuntz Rachael
|
Jul/Aug 2003
Pg. 266-270
|
Coenzyme Q10 Supplementation in the Treatment of Heart Disease
Bramwell Bethany L
|
Mar/Apr 2010
Pg. 108-111
|
Compounded Pimobendan for Canine Chronic Degenerative Mitral Valve Disease and Pulmonary Hypertension
Helms Scott R, Fox Samantha, Mixon William, Vail Jane
|
Jan/Feb 2012
Pg. 34-41
|
Basics of Compounding for Disorders of the External Ear
Allen Loyd V Jr
|
Jan/Feb 2004
Pg. 46-48
|
Skin Disorders in Horses; Case Report: Tripelennamine in the Treatment of Skin Disorders in Horses
Williams LaVonn A, Fokken Dawn
|
Sep/Oct 2009
Pg. 386-389
|
Natural Testosterone: Hormone of the Heart
Wright Jonathan V, Lenard Lane
|
Mar/Apr 1999
Pg. 88-98
|
Basics of Compounding for Raynaud's Disease
Glasnapp Andrew
|
Jul/Aug 2003
Pg. 288-291
|
Canine Public Servants: Caring for Drug Detection Dogs
Davidson Gigi S
|
Sep/Oct 2008
Pg. 384-390
|
Case Report: Pediatric Scar Management After Open-heart Surgery
Phan Ha, Harger Beau, Estrada Nick
|
Jul/Aug 2016
Pg. 277-280
|
Acidifying Agents, Featured Excipient:
Allen Loyd V Jr
|
Jul/Aug 1999
Pg. 309-310
|
Calculations
Prince Shelly J
|
Sep/Oct 2002
Pg. 387
|
Compounding for Endocrine Disorders in Adult Patients
Grajeda Betty Jo, Vail Jane
|
Jul/Aug 2005
Pg. 275-278
|
Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome
Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III
|
May/Jun 2010
Pg. 182-192
|
Attention Deficit Hyperactivity Disorder
Allen Loyd V Jr
|
Mar/Apr 1997
Pg. 87-89
|
Evaluating Transdermals Medication Froms for Veterinary Patients, Part 2
Davidson Gigi S
|
May/Jun 2001
Pg. 214-215
|
| Return to Top |
